Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
13 December 2013
Header
Header image
News

News

Horizon 2020 launched with 15 billion euros over first two years
13 December 2013

On Tuesday, the European Commission has for the first time presented calls for projects under Horizon 2020. Worth more than €15 billion over the first two years, the funding is intended to help boost Europe's knowledge-driven economy, and tackle issues that will make a difference in people's lives.

News

Innovative Medicines Initiative: Tracking Progress in Alzheimer's Research
13 December 2013

This Wednesday the UK is hosting the first ever G8 summit devoted to the topic of dementia. This initiative is timely: Dementia and dementia-related illnesses are an increasing concern for many societies facing ageing populations. The healthcare industry has long been aware of this growing threat, and many relevant research initiatives have been established to target this issue 

A recent study publication identifying the role of specific “biomarkers” in learning more about preclinical Alzheimer’s disease shows great promise for future diagnoses – and potential treatment. But what is a biomarker anyway? And how will this actually impact patients? EFPIA’s Director of Science Policy, Magda Chlebus, examines the progress achieved with support from the Innovative Medicines Initiative’s European Medical Information Framework (EMIF) project – and attempts to clear away the scientific jargon and explain the impact of study results on real-world patients – in a way they will understand.

From our blog

From our blog

Investing in Global Health – updating the case
09 December 2013 by Richard Torbett

20 years on since the World Bank published its seminal World Development Report, an impressive list of authors has come together under the auspices of [...] Read more

From our blog

Research Consortia Taking Off
12 December 2013 by Richard Bergström

During yesterday’s G8 Summit on Dementia, the UK announced a new £3 million (approximately €3.6) Dementia Consortium, which brings together researchers from the charitable, academic [...] Read more

From our blog

When in a hole, stop digging! Why growth policy in Greece needs a rethink
13 December 2013 by Richard Torbett

We all know that Greece has been at the centre of debate about the Euro-zone crisis. TV images of protestors in the streets, political turmoil [...] Read more

Events calendar

Events Calendar

The Pharma Summit 2014
On 13/03/2014 (London)

In the last decade, life science-based innovations have been incremental rather than radical. Onerous regulations that differ from country to country, high product development costs [...] Read more

What we are reading

What we are reading

Global Diffusion of Healthcare Innovation (GDHI) Report
13 December 2013

Innovation is what moves the research-based pharmaceutical industry forward; it's what we depend on to bring new and improved medicines to patients. However innovation can only help us achieve the aim of improving health outcomes if it is appropriately implemented. What enables the adoption of innovation? How are different countries succeeding in bringing innovation to patients? These are some of the questions addressed in the Global Diffusion of Healthcare Innovation (GDHI) Report, presented this week at the WISH (World Innovation Summit for Health) Conference in Qatar this week.

Read more

What we are reading

Malaria control efforts saved 3.3 million since 2000, WHO says
13 December 2013

This week, the World Organization announced that global efforts to curb malaria have saved the lives of 3.3 million people since 2000. The World Malaria Report 2013 demonstrates how expanded preventative and control measures -- i.e. the use of mosquito nets -- are making a real impact. This Reuters article reveals how investments on malaria control are paying off. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail